Earnings Preview For Renalytix - Renalytix (NASDAQ:RNLX)

Logo BenzingaBenzinga
2023-06-08 15:00:38  • 2 mins

Renalytix RNLX is set to give its latest quarterly earnings report on Friday, 2023-06-09. Here's what investors need to know before the announcement.

Analysts estimate that Renalytix will report an earnings per share (EPS) of $-0.12.

Renalytix bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.00, which was followed by a 7.56% increase in the share price the next day.

Here's a look at Renalytix's past performance and the resulting price change:

Continue read on benzinga.com

Fintel reports that on September 22, 2023, Citigroup maintained coverage of Terex ( NYSE:TEX ) with a Neutral recommendation. Analyst Price Forecast Suggests...
Logo NasdaqNasdaq
2023-09-23 03:37:30  • 1 min
Fintel reports that on September 22, 2023, Benchmark maintained coverage of National Cinemedia ( NASDAQ:NCMI ) with a Speculative Buy recommendation. Analyst...
Logo NasdaqNasdaq
2023-09-23 04:04:57  • 1 min
Fintel reports that on September 22, 2023, RBC Capital reiterated coverage of Factset Research Systems ( NYSE:FDS ) with a Sector Perform recommendation....
Logo NasdaqNasdaq
2023-09-23 06:20:47  • 1 min
Fintel reports that on September 22, 2023, Morgan Stanley maintained coverage of Trane Technologies plc - ( NYSE:TT ) with a Overweight recommendation....
Logo NasdaqNasdaq
2023-09-23 01:04:21  • 1 min
Intellia Therapeutics (NASDAQ: NTLA) and Rocket Pharmaceuticals (NASDAQ: RCKT) are gene-editing biotechs that want to offer what few others can: cures for...
Fintel reports that on September 21, 2023, B of A Securities upgraded their outlook for Nutanix Inc - ( NASDAQ:NTNX ) from Neutral to Buy. Analyst Price...
Logo NasdaqNasdaq
2023-09-22 02:32:42  • 1 min
Fintel reports that on September 22, 2023, B of A Securities maintained coverage of Factset Research Systems ( NYSE:FDS ) with a Neutral recommendation....
Logo NasdaqNasdaq
2023-09-23 06:20:41  • 1 min
Fintel reports that on September 22, 2023, BMO Capital maintained coverage of Factset Research Systems ( NYSE:FDS ) with a Market Perform recommendation....
Logo NasdaqNasdaq
2023-09-23 06:20:54  • 1 min
Fintel reports that on September 22, 2023, Needham reiterated coverage of Harmony Biosciences Holdings ( NASDAQ:HRMY ) with a Buy recommendation. Analyst...
Logo NasdaqNasdaq
2023-09-23 20:09:58  • 1 min
Fintel reports that on September 22, 2023, HC Wainwright & Co. maintained coverage of Travere Therapeutics ( NASDAQ:TVTX ) with a Buy recommendation....
Logo NasdaqNasdaq
2023-09-22 17:34:05  • 1 min
Fintel reports that on September 22, 2023, Morgan Stanley maintained coverage of Factset Research Systems ( NYSE:FDS ) with a Underweight recommendation....
Logo NasdaqNasdaq
2023-09-23 06:20:42  • 1 min
Travere Therapeutics Inc TVTX announced topline two-year confirmatory secondary endpoint results from its head-to-head Phase 3 PROTECT Study of Filspari...
Logo BenzingaBenzinga
2023-09-21 13:42:33  • 1 min
Fintel reports that on September 22, 2023, Morgan Stanley reiterated coverage of XPeng Inc - ADR ( NYSE:XPEV ) with a Overweight recommendation. Analyst...
Logo NasdaqNasdaq
2023-09-23 04:49:22  • 1 min
Fintel reports that on September 22, 2023, Piper Sandler maintained coverage of DENTSPLY Sirona ( NASDAQ:XRAY ) with a Neutral recommendation. Analyst Price...
Logo NasdaqNasdaq
2023-09-23 03:49:46  • 1 min
Fintel reports that on September 22, 2023, Guggenheim reiterated coverage of Immunovant ( NASDAQ:IMVT ) with a Buy recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-23 20:09:34  • 1 min
Fintel reports that on September 22, 2023, HSBC initiated coverage of Target ( NYSE:TGT ) with a Hold recommendation. Analyst Price Forecast Suggests 32.02%...
Logo NasdaqNasdaq
2023-09-23 01:02:32  • 1 min
Fintel reports that on September 22, 2023, Barclays maintained coverage of UDR ( NYSE:UDR ) with a Overweight recommendation. Analyst Price Forecast Suggests...
Logo NasdaqNasdaq
2023-09-23 05:16:18  • 1 min
Symbiotic (NASDAQ: SYM) went public by merging with a special purpose acquisition company (SPAC) on June 8, 2022. The developer of artificial intelligence...
Logo NasdaqNasdaq
2023-09-22 10:14:00  • 2 mins
Fintel reports that on September 22, 2023, RBC Capital reiterated coverage of 89bio ( NASDAQ:ETNB ) with a Outperform recommendation. Analyst Price Forecast...
Logo NasdaqNasdaq
2023-09-23 08:29:10  • 1 min
Voya Infrastructure, Industrials and Materials Fund said on September 15, 2023 that its board of directors declared a regular quarterly dividend of $0.23 per...
Logo NasdaqNasdaq
2023-09-23 14:10:50  • 1 min